ClinicalTrials.gg
CompletedNCT01833442Updated Oct 11, 2017

Randomized Controlled Meditation Trial for Treating OCD

An interventional study of Kundalini Yoga Meditation and Relaxation Response Meditation in OCD, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-10-11.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The trial objective is to compare two very different meditation protocols (Kundalini Yoga and Relaxation Response meditation techniques) to help the OCD treatment.

Read the detailed description

The proposed trial comparing the two different meditation protocols is expected to have two phases: 0-month to 4.5-month period where we compare the Kundalini Yoga protocol with Relaxation Response meditation technique, both on the primary efficacy variable using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and some if not most of the secondary variables using The Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS), Clinical Global Impressions (CGI), Profile of Mood States (POMS), Beck Anxiety Inventory (Beck-A), Beck Depression Inventory (Beck-D), and SF-36 Health Status Questionnaire (SF36). Participants will go to the hospital once a week for a 1,5 hour meditation class.After 4.5-months, all patients will be evaluated and merged together into a single group. Patients will then receive 09 to 12 more months of the meditation protocol. The investigators are expecting to recruit 50 to 60 patients to start. Patients will be blinded to the content of the protocol in the other group at baseline and until one group shows greater efficacy on the primary efficacy variable. The intake physician will be blinded to the treatment groups of the patients.

02

Conditions studied

  • OCD

Keywords

  • OCD
  • YBOCS
03

In context

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,032 studies on the registry; 93 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of OCD for at least 6 months.
  • A minimum score of 16 on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for the 10-item total score at the baseline screening will be required.
  • The patient must sign and been provided with a copy of an Assent Form for their reference.

Exclusion criteria

Exclusion Criteria:

  • Psychoactive prescription medications other than those prescribed for OCD.
  • Spinal problems, or other physically limiting problems.
  • Clinical diagnosis of hypertension, or other cardiovascular problems.
  • Clinical diagnosis of Parkinson's disease.
  • Clinical diagnosis of major depressive disorder with psychotic features, schizophrenia, bipolar disorder, mental retardation, anorexia nervosa, bulimia nervosa, autistic disorder, Asperger's disorder and other forms of pervasive developmental disorder, or traumatic brain.
  • Clinical diagnosis of Tourette's Syndrome.
  • Patients without regular and reliable transportation to the study site.
  • Patients who choose not to participate in meditation and/or chanting (out loud or silently) for personal or religious reasons.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Kundalini Yoga Meditation

    Kundalini Yoga Meditation is going to be use as therapy for OCD, and it will be compare with Relaxation Response Meditation.

    Behavioral: Kundalini Yoga Meditation

  • Active comparator
    Relaxation Response Meditation

    Relaxation Response Meditation is going to be use as therapy for OCD, and it will be compare with Kundalini Yoga Meditation.

    Behavioral: Relaxation Response Meditation

Interventions

  • BehavioralKundalini Yoga Meditation

    The trial will compare two very different meditation protocols. After the 4.5 month the patients will be reevaluated, and all patients will be merged together into a single group. Patients will then receive 9 - 12 more months of the meditation protocol.

  • BehavioralRelaxation Response Meditation

    The trial will compare two very different meditation protocols. After the 4.5 month the patients will be reevaluated, and all patients will be merged together into a single group. Patients will then receive 9 - 12 more months of the meditation protocol.

06

What researchers measure

Primary outcomes

  1. The Yale-Brown Obsessive Compulsive Scale (YBOCS)

    The Yale-Brown Obsessive Compulsive Scale, sometimes referred to as Y-BOCS, is a test to rate the severity of obsessive-compulsive disorder (OCD) symptoms.

    Time frame: Up to 16 months

Secondary outcomes

  1. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS)

    The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.

    Time frame: Up to 16 months

  2. Clinical Global Impressions (CGI)

    Time frame: Up to 16 months

  3. Profile of Mood States (POMS)

    Time frame: Up to 16 months

  4. Beck Anxiety Inventory (Beck-A)

    Time frame: Up to 16 months

  5. Beck Depression Inventory (Beck-D)

    Time frame: Up to 16 months

  6. SF-36 Health Status Questionnaire (SF36)

    Time frame: Up to 16 months

07

Study locations

1 site
  • University of Sao Paulo
    São Paulo, São Paulo 01454-010, Brazil
08

References and documents

Publications

  • Shannahoff-Khalsa D, Fernandes RY, Pereira CAB, March JS, Leckman JF, Golshan S, Vieira MSR, Polanczyk GV, Miguel EC, Shavitt RG. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial. Front Psychiatry. 2019 Nov 11;10:793. doi: 10.3389/fpsyt.2019.00793. eCollection 2019. PubMed 31780963 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01833442
Responsible party
Euripedes C. Miguel (Chairmain of psychiatry Departament of University os Sao Paulo, University of Sao Paulo) — Principal investigator
First posted
Apr 16, 2013
Start date
Mar 2011
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Oct 11, 2017

Study contacts

Euripedes C Miguel, PHD
principal investigator · University of Sao Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion